Inactivated Poliovirus Vaccine (ipv) - Infectious Diseases

Relevant Publications

Coverage of the Combined DTaP-IPV/Hib Vaccine Among Children Aged 2-18 Months - 9 PLADs, China, 2019-2021.

Issue Release: 2024

Serological responses to immunization during nephrosis in infants with congenital nephrotic syndrome of the Finnish type.

Issue Release: 2024

A randomized, active-controlled, multi-centric, phase-II clinical study to assess safety and immunogenicity of a fully liquid DTwP-HepB-IPV-Hib hexavalent vaccine (HEXASIIL®) in Indian toddlers.

Issue Release: 2024

Assessing the mucosal intestinal and systemic humoral immunity of sequential schedules of inactivated poliovirus vaccine and bivalent oral poliovirus vaccine for essential immunization in Bangladesh: An open-label, randomized controlled trial.

Issue Release: 2024

Use of Haemophilus influenzae Type b-Containing Vaccines Among American Indian and Alaska Native Infants: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.

Issue Release: 2024

Effectiveness of poliovirus vaccines against circulating vaccine-derived type 2 poliomyelitis in Nigeria between 2017 and 2022: a case-control study.

Issue Release: 2024

Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global Acceptance.

Issue Release: 2024

A phase 3 randomized, open-label study evaluating the immunogenicity and safety of concomitant and staggered administration of a live, pentavalent rotavirus vaccine and an inactivated poliomyelitis vaccine in healthy infants in China.

Issue Release: 2024

Modeling undetected poliovirus circulation following the 2022 outbreak in the United States.

Issue Release: 2024

Vitamin D Supplementation and Prior Oral Poliovirus Vaccination Decrease Odds of COVID-19 Outcomes among Adults Recently Inoculated with Inactivated Poliovirus Vaccine.

Issue Release: 2024

A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL) in infants.

Issue Release: 2024

Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis.

Issue Release: 2024

Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in routine immunization.

Issue Release: 2024

Intestinal mucosal immunity is unimportant for polio eradication: the failure of oral polio vaccination.

Issue Release: 2024

Immune Persistence following Primary Immunization and the Immunogenicity and Safety of a Booster Dose of a Multidose Sabin Strain-Based Inactivated Polio Vaccine in Infants Aged 18 Months.

Issue Release: 2024

Monitoring the evolution of vaccine-derived poliovirus in East and Southern African countries, 2010 - 2021.

Issue Release: 2024

Exploring the path to polio eradication: insights from consecutive seroprevalence surveys among Pakistani children.

Issue Release: 2024

Immune persistence after different polio sequential immunization schedules in Chinese infants.

Issue Release: 2024

The Immunogenicity of Monovalent Oral Poliovirus Vaccine Type 1 (mOPV1) and Inactivated Poliovirus Vaccine (IPV) in the EPI Schedule of India.

Issue Release: 2024

Nasal and pharyngeal mucosal immunity to poliovirus in children following routine immunization with inactivated polio vaccine (IPV) in the United States of America.

Issue Release: 2024

How is Prevalence Calculated?

What Role Do Public Health Organizations Play?

How Does the Innate Immune System Recognize Pathogens?

Which Microorganisms Commonly Colonize Humans?

What are the Symptoms of E. Coli Infection?

Is Colonization Harmful?

Can Climate Change Influence Antibiotic Resistance?

What are the Implications of Genomics for Treatment?

What Treatments are Available?

How Can Rabies Be Prevented?

Inactivated Poliovirus Vaccine (ipv) - Infectious Diseases

Relevant Publications

Partnered Content Networks

Relevant Topics